Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%

Pfizer said it plans to submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, to the U.S. Food and Drug Administration as part of the emergency use application it opened in October.

from Markets-Economic Times https://ift.tt/3wjEgUG